Cargando…
Alendronate sodium/vitamin D(3) combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension
SUMMARY: This study compares efficacy of ALN/D5600 versus that of calcitriol in osteoporotic Chinese postmenopausal women. ALN/D5600 produced greater bone mineral density (BMD) increases, greater bone turnover marker decreases, and less vitamin D insufficiency. This study provided detailed clinical...
Autores principales: | Zhang, Z. L., Liao, E. Y., Xia, W. B., Lin, H., Cheng, Q., Wang, L., Hao, Y. Q., Chen, D. C., Tang, H., De Peng, Y., You, L., He, L., Hu, Z. H., Song, C. L., Wei, F., Wang, J., Zhang, L., Santora, A. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532726/ https://www.ncbi.nlm.nih.gov/pubmed/25929192 http://dx.doi.org/10.1007/s00198-015-3141-y |
Ejemplares similares
-
Erratum to: Alendronate sodium/vitamin D(3) combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension
por: Zhang, Z. L., et al.
Publicado: (2015) -
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
por: Bone, Henry G, et al.
Publicado: (2018) -
Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
por: Hiligsmann, M., et al.
Publicado: (2021) -
Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
por: Mok, Ji Oh, et al.
Publicado: (2013) -
Fracture Preventing Effects of Maxmarvil® Tablets (Alendronate 5 mg + Calcitriol 0.5 µg) in Patients with Osteoporosis
por: Yoo, Jun-Il, et al.
Publicado: (2017)